StockWatch
·
Pharmaceuticals
Board Meeting7 Aug 2026, 04:41 pm

Rubicon Research Board Meeting on Aug 14 to Approve Q1 FY27 Results

AI Summary

Rubicon Research Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item is to consider and approve the un-audited standalone and consolidated financial results for the first quarter ended June 30, 2026. In compliance with SEBI regulations and the company's insider trading code, the trading window for company shares has been closed from July 1, 2026, and will reopen 48 hours after the financial results are announced.

Key Highlights

  • Board meeting scheduled for August 14, 2026.
  • To approve un-audited standalone and consolidated financial results.
  • Financial results pertain to the quarter ended June 30, 2026.
  • Trading window closed from July 1, 2026, until results announcement plus 48 hours.